Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
Hasniza Zaman Huri,1,2 Doris Yew Hui Ling,1 Wan Azman Wan Ahmad2,3 1Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 2Clinical Investigation Centre, University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Malaysia; 3Cardiology Unit, Department of Med...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-08-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/association-between-glycemic-control-and-antidiabetic-drugs-in-type-2--peer-reviewed-article-DDDT |
| _version_ | 1819026427254669312 |
|---|---|
| author | Huri HZ Ling DYH Ahmad WAW |
| author_facet | Huri HZ Ling DYH Ahmad WAW |
| author_sort | Huri HZ |
| collection | DOAJ |
| description | Hasniza Zaman Huri,1,2 Doris Yew Hui Ling,1 Wan Azman Wan Ahmad2,3 1Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 2Clinical Investigation Centre, University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Malaysia; 3Cardiology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Purpose: Cardiovascular disease (CVD) is a macrovascular complication in patients with type 2 diabetes mellitus (T2DM). To date, glycemic control profiles of antidiabetic drugs in cardiovascular (CV) complications have not been clearly elucidated. Therefore, this study was conducted retrospectively to assess the association of antidiabetic drugs and glycemic control with CV profiles in T2DM patients. The association of concurrent medications and comorbidities with glycemic control was also investigated.Methods: A total of 220 T2DM patients from the University of Malaya Medical Centre, Malaysia, who had at least one CV complication and who had been taking at least one antidiabetic drug for at least 3 months, were included. The associations of antidiabetics, cardiovascular diseases, laboratory parameters, concurrent medications, comorbidities, demographics, and clinical characteristics with glycemic control were investigated.Results: Sulfonylureas in combination (P=0.002) and sulfonylurea monotherapy (P<0.001) were found to be associated with good glycemic control, whereas insulin in combination (P=0.051), and combination biguanides and insulin therapy (P=0.012) were found to be associated with poor glycemic control. Stroke (P=0.044) was the only type of CVD that seemed to be significantly associated with good glycemic control. Other factors such as benign prostatic hyperplasia (P=0.026), elderly patients (P=0.018), low-density lipoprotein cholesterol levels (P=0.021), and fasting plasma glucose (P<0.001) were found to be significantly correlated with good glycemic control.Conclusion: Individualized treatment in T2DM patients with CVDs can be supported through a better understanding of the association between glycemic control and CV profiles in T2DM patients. Keywords: glycemic control, antidiabetic drugs, type 2 diabetes mellitus, cardiovascular disease |
| first_indexed | 2024-12-21T05:26:24Z |
| format | Article |
| id | doaj.art-e3494c3e385a40c181575acbe0691423 |
| institution | Directory Open Access Journal |
| issn | 1177-8881 |
| language | English |
| last_indexed | 2024-12-21T05:26:24Z |
| publishDate | 2015-08-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Drug Design, Development and Therapy |
| spelling | doaj.art-e3494c3e385a40c181575acbe06914232022-12-21T19:14:40ZengDove Medical PressDrug Design, Development and Therapy1177-88812015-08-012015default4735474923190Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complicationsHuri HZLing DYHAhmad WAWHasniza Zaman Huri,1,2 Doris Yew Hui Ling,1 Wan Azman Wan Ahmad2,3 1Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 2Clinical Investigation Centre, University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Malaysia; 3Cardiology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia Purpose: Cardiovascular disease (CVD) is a macrovascular complication in patients with type 2 diabetes mellitus (T2DM). To date, glycemic control profiles of antidiabetic drugs in cardiovascular (CV) complications have not been clearly elucidated. Therefore, this study was conducted retrospectively to assess the association of antidiabetic drugs and glycemic control with CV profiles in T2DM patients. The association of concurrent medications and comorbidities with glycemic control was also investigated.Methods: A total of 220 T2DM patients from the University of Malaya Medical Centre, Malaysia, who had at least one CV complication and who had been taking at least one antidiabetic drug for at least 3 months, were included. The associations of antidiabetics, cardiovascular diseases, laboratory parameters, concurrent medications, comorbidities, demographics, and clinical characteristics with glycemic control were investigated.Results: Sulfonylureas in combination (P=0.002) and sulfonylurea monotherapy (P<0.001) were found to be associated with good glycemic control, whereas insulin in combination (P=0.051), and combination biguanides and insulin therapy (P=0.012) were found to be associated with poor glycemic control. Stroke (P=0.044) was the only type of CVD that seemed to be significantly associated with good glycemic control. Other factors such as benign prostatic hyperplasia (P=0.026), elderly patients (P=0.018), low-density lipoprotein cholesterol levels (P=0.021), and fasting plasma glucose (P<0.001) were found to be significantly correlated with good glycemic control.Conclusion: Individualized treatment in T2DM patients with CVDs can be supported through a better understanding of the association between glycemic control and CV profiles in T2DM patients. Keywords: glycemic control, antidiabetic drugs, type 2 diabetes mellitus, cardiovascular disease http://www.dovepress.com/association-between-glycemic-control-and-antidiabetic-drugs-in-type-2--peer-reviewed-article-DDDT |
| spellingShingle | Huri HZ Ling DYH Ahmad WAW Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications Drug Design, Development and Therapy |
| title | Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications |
| title_full | Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications |
| title_fullStr | Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications |
| title_full_unstemmed | Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications |
| title_short | Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications |
| title_sort | association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications |
| url | http://www.dovepress.com/association-between-glycemic-control-and-antidiabetic-drugs-in-type-2--peer-reviewed-article-DDDT |
| work_keys_str_mv | AT hurihz associationbetweenglycemiccontrolandantidiabeticdrugsintype2diabetesmellituspatientswithcardiovascularcomplications AT lingdyh associationbetweenglycemiccontrolandantidiabeticdrugsintype2diabetesmellituspatientswithcardiovascularcomplications AT ahmadwaw associationbetweenglycemiccontrolandantidiabeticdrugsintype2diabetesmellituspatientswithcardiovascularcomplications |